ÁNGELA
GUTIÉRREZ CAMINO
Hospital Universitario La Paz
Madrid, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario La Paz (10)
2020
-
Role of rs10406069 in miR-5196 in hyperdiploid childhood acute lymphoblastic leukemia
Epigenomics, Vol. 12, Núm. 22, pp. 1949-1955
2018
-
Involvement of SNPs in miR-3117 and miR-3689d2 in childhood acute lymphoblastic leukemia risk
Oncotarget, Vol. 9, Núm. 33, pp. 22907-22914
-
Involvement of miRNA polymorphism in mucositis development in childhood acute lymphoblastic leukemia treatment
Pharmacogenomics, Vol. 19, Núm. 18, pp. 1403-1412
-
Mir-pharmacogenetics of Vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia
Pharmacogenomics Journal, Vol. 18, Núm. 6, pp. 704-712
-
Pharmacoepigenetics in childhood acute lymphoblastic leukemia: Involvement of miRNA polymorphisms in hepatotoxicity
Epigenomics, Vol. 10, Núm. 4, pp. 409-417
2017
2016
-
MIR-pharmacogenetics of methotrexate in childhood B-cell acute lymphoblastic leukemia
Pharmacogenetics and Genomics, Vol. 26, Núm. 11, pp. 517-525
-
Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia
Pharmacogenomics, Vol. 17, Núm. 7, pp. 731-741
2014
-
Noncoding RNA-related polymorphisms in pediatric acute lymphoblastic leukemia susceptibility
Pediatric Research, Vol. 75, Núm. 6, pp. 767-773
-
Pharmacogenetics of MicroRNAs and MicroRNAs biogenesis machinery in pediatric acute lymphoblastic leukemia
PLoS ONE, Vol. 9, Núm. 3